Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues

被引:2
|
作者
Vieira de Ribeiro, Ana Julia [1 ]
Sandim, Vanessa [1 ]
Ornellas, Antonio Augusto [2 ,3 ]
Reis, Rodrigo Siqueira [4 ]
Domont, Gilberto [4 ]
Alves, Gilda [1 ]
机构
[1] Inst Nacl Canc, Appl Genet Lab, Div Hematol, BR-20230130 Rio De Janeiro, RJ, Brazil
[2] Inst Nacl Canc, Div Urol, BR-20230130 Rio De Janeiro, RJ, Brazil
[3] Hosp Mario Kroeff, Div Urol, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Rio de Janeiro, Inst Chem, Prote Unit, BR-21941 Rio De Janeiro, RJ, Brazil
来源
INTERNATIONAL BRAZ J UROL | 2013年 / 39卷 / 01期
关键词
Carcinoma; Renal Cell; Proteome; Electrophoresis; Polyacrylamide Gel; Kidney; OXIDATIVE STRESS; MESSENGER-RNA; CANCER-CELLS; IDENTIFICATION; EXPRESSION; PROHIBITIN; BIOMARKER;
D O I
10.1590/S1677-5538.IBJU.2013.01.11
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We attempted to detect, for the first time in a Brazilian cohort, differences in protein expression between clear-cell renal cell carcinoma (ccRCC) and their normal adjacent tissues, aiming to identify biomarkers and/or therapeutic target candidates for this disease. Material and Methods: Twenty-four ccRCC and adjacent normal tissues were collected after surgery and their protein extracts were quantified, pooled and separated by two-dimensional polyacrylamide gel electrophoresis (2DE), followed by statistical analysis of the stained gels. Spots of interest were excised from the gels, digested with trypsin and identified by MALDI-TOF-TOF mass spectrometry. Results: Twenty-six differential spots were detected between the two classes of tissues, among which twenty were identified by mass spectrometry and sixteen were found to be non-redundant. Eleven proteins were either underexpressed or undetected in the ccRCC extracts, such as prohibitin and peroxiredoxin-3, whereas five were found to be overexpressed or exclusively detected in the ccRCC extract, including alpha beta crystalin and heat shock protein 27. Conclusions: Several proteins were detected at differential levels when compared to normal adjacent tissues, and, moreover, many have been previously described by their relationship with RCC. Therefore, this work corroborates previous reports on the search for biomarkers for ccRCC, as well as it points out new candidates that may be validated in future studies.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 50 条
  • [31] Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis
    Thi Oanh Bui
    Van Tu Dao
    Van Tai Nguyen
    Feugeas, Jean-Paul
    Pamoukdjian, Frederic
    Bousquet, Guilhem
    EUROPEAN UROLOGY, 2022, 81 (04) : 349 - 361
  • [32] Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
    Lee, Cheol
    Park, Jeong-Whan
    Suh, Ja Hee
    Nam, Kyung Han
    Moon, Kyung Chul
    KOREAN JOURNAL OF PATHOLOGY, 2013, 47 (05) : 426 - 432
  • [33] Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis
    Yuan, Lushun
    Zeng, Guang
    Chen, Liang
    Wang, Gang
    Wang, Xiaolong
    Cao, Xinyue
    Lu, Mengxin
    Liu, Xuefeng
    Qian, Guofeng
    Xiao, Yu
    Wang, Xinghuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14 (03): : 266 - 279
  • [34] Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC
    Szabo, Zsuzsanna
    Szegedi, Krisztian
    Gombos, Katalin
    Mahua, Choudhury
    Flasko, Tibor
    Harda, Kristof
    Halmos, Gabor
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (12) : 533.e21 - 533.e27
  • [35] The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma
    Mizutani, A.
    Koinuma, D.
    Seimiya, H.
    Miyazono, K.
    ONCOGENE, 2016, 35 (27) : 3514 - 3523
  • [36] T2 clear cell renal cell carcinoma is a rare entity: A study of 120 clear cell renal cell carcinomas
    Bonsib, SM
    JOURNAL OF UROLOGY, 2005, 174 (04) : 1199 - 1202
  • [37] miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer
    Fan, Yang
    Ma, Xin
    Li, Hongzhao
    Gao, Yu
    Huang, Qingbo
    Zhang, Yu
    Bao, Xu
    Du, Qingshan
    Luo, Guoxiong
    Liu, Kan
    Meng, Qingyu
    Zhao, Chaofei
    Zhang, Xu
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (03) : 547 - 560
  • [38] Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy
    Verbiest, Annelies
    Couchy, Gabrielle
    Job, Sylvie
    Caruana, Laure
    Lerut, Evelyne
    Oyen, Raymond
    de Reynies, Aurelien
    Tosco, Lorenzo
    Joniau, Steven
    Van Poppel, Hendrik
    Van Raemdonck, Dirk
    Van Den Eynde, Kathleen
    Wozniak, Agnieszka
    Zucman-Rossi, Jessica
    Beuselinck, Benoit
    EUROPEAN UROLOGY, 2018, 74 (04) : 474 - 480
  • [39] A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma
    Rappold, Phillip M.
    Vuong, Lynda
    Leibold, Josef
    Chakiryan, Nicholas H.
    Curry, Michael
    Kuo, Fengshen
    Sabio, Erich
    Jiang, Hui
    Nixon, Briana G.
    Liu, Ming
    Berglund, Anders E.
    Silagy, Andrew W.
    Mascareno, Eduardo A.
    Golkaram, Mahdi
    Marker, Mahtab
    Reising, Albert
    Savchenko, Alexander
    Millholland, John
    Chen, Ying-Bei
    Russo, Paul
    Coleman, Jonathan
    Reznik, Ed
    Manley, Brandon J.
    Ostrovnaya, Irina
    Makarov, Vladimir
    DiNatale, Renzo G.
    Blum, Kyle A.
    Ma, Xiaoxiao
    Chowell, Diego
    Li, Ming O.
    Solit, David B.
    Lowe, Scott W.
    Chan, Timothy A.
    Motzer, Robert J.
    Voss, Martin H.
    Hakimi, A. Ari
    CANCER DISCOVERY, 2022, 12 (10) : 2308 - 2329
  • [40] High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma
    Na, Ning
    Li, Heng
    Xu, Chengfang
    Miao, Bin
    Hong, Liangqing
    Huang, Zhengyu
    Jiang, Qiu
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 279 - 285